CD4 and myeloid sarcoma: In multiple sclerosis (MS), a prototypical autoimmune demyelinating disorder mediated by CD4+ Th1/Th17 responses, oxidative stress, and mitochondrial dysfunction exacerbates chronic neurodegeneration.